Understanding COVID-19 in Africa

The coronavirus disease 2019 (COVID-19) pandemic has spread to all 55 countries in Africa. The prevalence is highly heterogeneous, and the majority of cases are asymptomatic. Several factors are thought to explain heterogeneity of COVID-19 in Africa, including the level of containment measures, demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tessema, Sofonias K., Nkengasong, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222946/
https://www.ncbi.nlm.nih.gov/pubmed/34168345
http://dx.doi.org/10.1038/s41577-021-00579-y
_version_ 1783711590371033088
author Tessema, Sofonias K.
Nkengasong, John N.
author_facet Tessema, Sofonias K.
Nkengasong, John N.
author_sort Tessema, Sofonias K.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has spread to all 55 countries in Africa. The prevalence is highly heterogeneous, and the majority of cases are asymptomatic. Several factors are thought to explain heterogeneity of COVID-19 in Africa, including the level of containment measures, demographic aspects, climate and environmental factors, host genetics and immune factors. Here, we discuss the prevalence of COVID-19 in Africa, the status of serological studies, COVID-19 and comorbidities, as well as the spread of SARS-CoV-2 variants and the status of vaccine roll-outs in Africa.
format Online
Article
Text
id pubmed-8222946
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82229462021-06-25 Understanding COVID-19 in Africa Tessema, Sofonias K. Nkengasong, John N. Nat Rev Immunol Comment The coronavirus disease 2019 (COVID-19) pandemic has spread to all 55 countries in Africa. The prevalence is highly heterogeneous, and the majority of cases are asymptomatic. Several factors are thought to explain heterogeneity of COVID-19 in Africa, including the level of containment measures, demographic aspects, climate and environmental factors, host genetics and immune factors. Here, we discuss the prevalence of COVID-19 in Africa, the status of serological studies, COVID-19 and comorbidities, as well as the spread of SARS-CoV-2 variants and the status of vaccine roll-outs in Africa. Nature Publishing Group UK 2021-06-24 2021 /pmc/articles/PMC8222946/ /pubmed/34168345 http://dx.doi.org/10.1038/s41577-021-00579-y Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Tessema, Sofonias K.
Nkengasong, John N.
Understanding COVID-19 in Africa
title Understanding COVID-19 in Africa
title_full Understanding COVID-19 in Africa
title_fullStr Understanding COVID-19 in Africa
title_full_unstemmed Understanding COVID-19 in Africa
title_short Understanding COVID-19 in Africa
title_sort understanding covid-19 in africa
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222946/
https://www.ncbi.nlm.nih.gov/pubmed/34168345
http://dx.doi.org/10.1038/s41577-021-00579-y
work_keys_str_mv AT tessemasofoniask understandingcovid19inafrica
AT nkengasongjohnn understandingcovid19inafrica

Ejemplares similares